These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 35248291)

  • 1. Non-surgical interventions for the treatment of masticatory muscular spasticity in patients with cerebral palsy. Systematic review of randomized clinical trials.
    Rocha MM; Martimbianco ALC; Beltramin RZ; Horliana ACRT; Santos EM; Mesquita-Ferrari RA; Fernandes KPS; Motta LJ; Turcio KH; Gonçalves MLL; Bussadori SK
    J Bodyw Mov Ther; 2022 Jan; 29():68-73. PubMed ID: 35248291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB; Rosales RL; Dressler D
    J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials.
    Farag SM; Mohammed MO; El-Sobky TA; ElKadery NA; ElZohiery AK
    JBJS Rev; 2020 Mar; 8(3):e0119. PubMed ID: 32224633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjunct therapies to improve outcomes after botulinum toxin injection in children: A systematic review.
    Mathevon L; Bonan I; Barnais JL; Boyer F; Dinomais M
    Ann Phys Rehabil Med; 2019 Jul; 62(4):283-290. PubMed ID: 30063979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity.
    Demetrios M; Khan F; Turner-Stokes L; Brand C; McSweeney S
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009689. PubMed ID: 23740539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.
    Ade-Hall RA; Moore AP
    Cochrane Database Syst Rev; 2000; (2):CD001408. PubMed ID: 10796784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.
    James E; Ellis C; Brassington R; Sathasivam S; Young CA
    Cochrane Database Syst Rev; 2022 May; 5(5):CD006981. PubMed ID: 35593746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate use in children with cerebral palsy.
    Hurley T; Zareen Z; Stewart P; McDonnell C; McDonald D; Molloy E
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD012756. PubMed ID: 34224134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin for the treatment of strabismus.
    Rowe FJ; Noonan CP
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006499. PubMed ID: 28253424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
    Koman LA; Paterson Smith B; Balkrishnan R
    Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessments and Interventions for Spasticity in Infants With or at High Risk for Cerebral Palsy: A Systematic Review.
    Ayala L; Winter S; Byrne R; Fehlings D; Gehred A; Letzkus L; Noritz G; Paton MCB; Pietruszewski L; Rosenberg N; Tanner K; Vargus-Adams J; Novak I; Maitre NL
    Pediatr Neurol; 2021 May; 118():72-90. PubMed ID: 33563492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for eye movement disorders due to acquired brain injury.
    Rowe FJ; Hanna K; Evans JR; Noonan CP; Garcia-Finana M; Dodridge CS; Howard C; Jarvis KA; MacDiarmid SL; Maan T; North L; Rodgers H
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011290. PubMed ID: 29505103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory muscle training in children and adults with neuromuscular disease.
    Silva IS; Pedrosa R; Azevedo IG; Forbes AM; Fregonezi GA; Dourado Junior ME; Lima SR; Ferreira GM
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011711. PubMed ID: 31487757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for managing halitosis.
    Kumbargere Nagraj S; Eachempati P; Uma E; Singh VP; Ismail NM; Varghese E
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012213. PubMed ID: 31825092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Oral Baclofen in the Treatment of Spasticity in Children and Adolescents With Cerebral Palsy.
    Navarrete-Opazo AA; Gonzalez W; Nahuelhual P
    Arch Phys Med Rehabil; 2016 Apr; 97(4):604-618. PubMed ID: 26321489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of extracorporeal shockwave therapy on muscle spasticity in patients with cerebral palsy: meta-analysis and systematic review.
    Kim HJ; Park JW; Nam K
    Eur J Phys Rehabil Med; 2019 Dec; 55(6):761-771. PubMed ID: 31615195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is botulinum toxin type A more effective and safer than other treatments for the management of lower limb spasticity in children with cerebral palsy? A Cochrane Review summary with commentary.
    Kim H; Kolaski K
    NeuroRehabilitation; 2021; 49(1):161-164. PubMed ID: 34366300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.